BioCentury
ARTICLE | Finance

Building Tenaya

Why Gladstone spinout Tenaya is a model investment for TCG's third fund

December 14, 2016 12:43 AM UTC

As the only non-angel investor in cardiovascular company Tenaya Therapeutics Inc.’s $50 million series A round, The Column Group is making good on its plans to invest more and syndicate less with its latest fund.

TCG committed $48 million. On Dec. 7, Tenaya closed the first $10 million tranche of the round...

BCIQ Company Profiles

Tenaya Therapeutics Inc.